Trials / Completed
CompletedNCT02818452
Glycemic Impact of Oatmeal Plus OatWellXF28
Affecting the Glycemic Impact of Quaker Instant Oatmeal by Adding OatWell28XF: a Dose-Response Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- PepsiCo Global R&D · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to determine the effect on glycemic responses of adding various doses of OatWell28XF to Quaker Instant Oatmeal in order to: 1) describe the dose-response curve and 2) If possible, identify the minimum level of OatWell28XF which, when added to a serving of Quaker Instant Oatmeal, would result in a glycemic response at least 20% less than that elicited by a β-glucan-free cereal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Oatmeal + OatWell28XF | Intervention involves consumption of one cereal in the beginning of each visit of the crossover sequence |
| OTHER | Oatmeal | |
| OTHER | Hot cereal |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2016-06-29
- Last updated
- 2016-12-07
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02818452. Inclusion in this directory is not an endorsement.